NCT02025608View on ClinicalTrials.gov

Autonomic Function and Cardiovascular Risk in Restless Legs Syndrome

PHASE4CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

December 31, 2013

Primary Completion Date

December 31, 2016

Study Completion Date

December 31, 2016

Conditions
Restless Legs Syndrome
Interventions
DRUG

Pramipexole

DRUG

Placebo

Trial Locations (2)

3010

Department of Neurology, Inselspital, Bern

6903

Neurocenter of Southern Switzerland, Lugano

All Listed Sponsors
collaborator

Insel Gruppe AG, University Hospital Bern

OTHER

collaborator

Cardiocentro Ticino

OTHER

lead

Mauro Manconi

OTHER

NCT02025608 - Autonomic Function and Cardiovascular Risk in Restless Legs Syndrome | Biotech Hunter | Biotech Hunter